Author:
Davis Michael C.,Horan William P.,Marder Stephen R.
Funder
Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs
Subject
Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology
Reference103 articles.
1. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia;Abi-Dargham;Neuroscientist: Rev. J. Bringing Neurobiol., Neurol. Psychiatry,2003
2. Negative symptoms in schizophrenia. Definition and reliability;Andreasen;Arch. Gen. Psychiatry,1982
3. Asenjo Lobos, C., Komossa, K., Rummel-Kluge, C., Hunger, H., Schmid, F., Schwarz, S., Leucht, S., 2010. Clozapine Versus Other Atypical Antipsychotics for Schizophrenia. Cochrane Database Syst. Rev., CD006633.
4. Validation of the 16-item negative symptom assessment;Axelrod;J. Psychiatr. Res.,1993
5. Estrogen augmentation in schizophrenia: a quantitative review of current evidence;Begemann;Schizophr. Res.,2012
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献